Related Experiment Video
Updated: Jun 12, 2026
10:32
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Sequencing protocols to genotype mdx, mdx(4cv), and mdx(5cv) mice
Glen B Banks1, Ariana C Combs, Jeffrey S Chamberlain
1Department of Neurology, University of Washington, Mail Stop 357720, 1959 NE Pacific St., Seattle, Washington 98195, USA.
Muscle & Nerve
|June 15, 2010
Summary
A new sequencing method accurately genotypes mouse dystrophin gene point mutations, avoiding false positives common with polymerase chain reaction (PCR) methods. This saves time and resources in research involving mdx, mdx(4cv), and mdx(5cv) mouse models.
Area of Science:
- Genetics and Genomics
- Molecular Biology
- Animal Models
Background:
- Polymerase chain reaction (PCR) genotyping for mouse dystrophin gene mutations can yield false positives.
- Inaccurate genotyping leads to wasted resources and incorrect experimental outcomes.
Purpose of the Study:
- To develop a simple and accurate sequencing method for mouse dystrophin gene point mutations.
- To improve genotyping accuracy for mdx, mdx(4cv), and mdx(5cv) mouse models.
Main Methods:
- Sequencing of point mutations in the mouse dystrophin gene.
- Distinguishing between wildtype, heterozygous, and mutant transcripts.
Main Results:
- The developed sequencing method provides clear differentiation of genotypes.
- Eliminates false positives associated with current PCR genotyping techniques.
Conclusions:
- This sequencing approach offers a reliable and cost-effective alternative for genotyping mouse dystrophin mutations.
- Accurate genotyping facilitates efficient research and resource management in studies using mdx mouse models.
